Research
Hormonal
GLP-1 receptor agonists are associated with greater reductions in body weight compared to lifestyle interventions and previous medications.
GLP-1 RAs may be a more effective option for weight loss compared to traditional lifestyle changes.
StrongSupportsmedium confidence
Studies show greater reductions in body weight with these medications compared to lifestyle intervention and previous medications.
Why this rating
Based on comparative studies referenced in the abstract.
Source
Glucagon‐like peptide‐1 receptor agonists discontinuation is higher in individuals with overweight and obesity without type 2 diabetes
Gregory J. Grosicki et al. · Diabetes Obesity and Metabolism · 2025
Meta-analysisCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →